Reprint

20th Anniversary of Pharmaceuticals

Advances in Pathophysiology, Pharmacology and Neuroprotection in Glaucoma

Edited by
October 2025
284 pages
  • ISBN 978-3-7258-5335-9 (Hardback)
  • ISBN 978-3-7258-5336-6 (PDF)

This is a Reprint of the Special Issue 20th Anniversary of Pharmaceuticals—Advances in Pathophysiology, Pharmacology and Neuroprotection in Glaucoma that was published in

Biology & Life Sciences
Public Health & Healthcare
Medicine & Pharmacology

Summary

The Special Issue Reprint encompassing peer-reviewed articles on glaucoma and neuroprotection is timely, as the constellation of eye diseases is ever-increasing as the world’s population ages. The aim of the Special Issue was to capture some leading aspects of on-going research into pathophysiology, genetics and current and future therapeutic treatment options to mitigate the signs and symptoms of these potentially blinding disorders, especially open-angle and normotensive glaucoma that affect millions worldwide. I hope that this collection of original research and review articles will spur further interest in these elements in the academic arena and in the biopharmaceutical industries.

Related Books

Glaucoma

Medicine & Pharmacology

New Insights into Glaucoma

Medicine & Pharmacology

Going for Gaps in Glaucoma

Medicine & Pharmacology

Ophthalmology

Medicine & Pharmacology

The recommendations have been generated using an AI system.